Fizerchain Ltd
Fizerchain Ltd

Category: Featured Blog

Trending In Lifesciences, COVID-19 Vaccine Related News

Currently, there are more than 160 potential vaccines for COVID-19 under development and experts suggest that a viable vaccine could be ready by the end of the year. Some experts ask for caution as this timeline is extremely optimistic, even unrealistic. With only a small number of those vaccine candidates actually being tested on humans and the fact that many of the other vaccine projects won’t survive beyond the laboratory stage, they could be right.

Even so, vaccine funding has been plentiful and a wide range of different approaches are being studied and this had led to collaborations being created between the small firms developing the vaccines and the large pharmaceutical companies who can mass produce them.

With that being said, we are going to take a look at some of the COVID-19 vaccines that are further along in testing than others and that seem much more promising. Let’s get started:

The Most Promising COVID-19 Vaccines

Novavax- developed by the U.S.-based company, Novavax, NVX-CoV2373 uses technology that generates antigens (that stimulate the immune system) derived from the coronavirus spike protein.

Sinopharm- an inactivated vaccine from Sinopharm Wuhan Biological Products Research Institute in China has been tested on 1,120 people ages 18-59 with a response rate of 97.6%.

Clover Biopharmaceuticals- China’s Clover Biopharmaceuticals’ protein-based vaccine is designed to resemble the spike protein on the virus. The company aims to conduct a global phase IIb/III study by the end of the year.

Moderna- Moderna’s mRNA-1273 vaccine uses messenger RNA, an approach that does not require a virus to make the vaccine. The company states that the ‘messenger RNA, or mRNA, carries instructions for making the spike protein, a key protein on the surface of the SARS-CoV-2 virus that allows the virus to enter cells when a person gets infected. When the vaccine with this instruction molecule is injected, it goes to the immune cells and instructs them to make copies of the spike protein, acting as if the cells have already been infected with the coronavirus. This allows other immune cells to develop ways to protect you and therefore gives you immunity.’

Inovio- Inovio’s vaccine, INO-4800, uses DNA designed to produce a specific immune response. Once the DNA is inside a cell, it instructs it to make many copies of the artificial DNA. This, in turn, stimulates the body’s natural immune response.

Contact Fizerchain

To learn more about the latest COVID-19 vaccine related news, contact Fizerchain today and speak with an experienced business consultant who can answer any questions you might have.

If you enjoyed this article, please feel free to share it on your favourite social media sites.

 

 

The New Normal For Business During The Pandemic – Complying With The New Regulations

Many countries and cities are cautiously relaxing coronavirus-related restrictions and as businesses are recovering, they need to implement new normal measures. This involves short- and long-term fixes to boost consumer confidence, so they will resume buying things again. The first phase of restarting business operations is by implementing changes to allay fears and keep employees safe. Consumers are already very conscious about health risks, whether imagined or real. In many places, we begin to see a flurry of activities. At the same time, businesses that proactively seek to mitigate health risks of COVID-19 will regain trust from consumers.

With that being said, we are going to take a look at some ways that businesses can comply with the new COVID-19 regulations:

Impose Company-Wide Social Distancing- social distancing is the basic strategy for preventing the spread of COVID-19 in workplace. It could be necessary to re-arrange your office layout to prevent co-workers from getting too close. They need to wear face masks at all times. Limit the number of employees in the meeting room and if possible, continue using Zoom or other teleconferencing platforms, although all employees are present at work.

Requite Regular Hand-Washing- educate employees about proper handwashing methods. It is always better to wash hands with running water and soap, than using hand sanitiser or disinfectant wipes. The WHO advises washing hands thoroughly for at least 20 seconds, including lathering spots under the nails and between fingers. Employees should be constantly reminded until regular handwashing becomes a workplace habit.

Perform Routine Cleaning- high-traffic areas should be cleaned up regularly, every 30 minutes or more often. This means that businesses may need to hire dedicated cleaning staffs who constantly disinfect risky areas. The constant presence of cleaning staffs will keep employees and customers feeling confident about the hygiene of the workplace and the store.

Require Sick Employees To Stay Home- if some employees are coughing and sneezing regularly, they must be required to stay at home. If they are showing mild symptoms, they can still continue working from home. For larger businesses that operate an infirmary with a full-time doctor and paramedic, it is recommended to invest on rapid diagnostic test kits.

Ask Customers To Maintain Safe Distance- it should be fairly easy to ask customers keep their distance. In fact, they will be reluctant to go to crowded indoor areas. Seats in waiting areas should be re-arranged and assign staff to direct customers.

Contact Fizerchain

To learn more about complying with the new post-COVID-19 regulations, contact Fizerchain today and speak with an experienced business consultant who can answer any questions you might have.

If you enjoyed this article, please feel free to share it on your favourite social media sites.